Delivery Order SPE2DE24DA017-SPE2D626F271L
- Not listed
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $5,932.74 to Arthrex Inc. for a Proximal Tenodesis Implant System, effective September 29, 2025, with an ultimate completion date of October 2, 2025. This fixed-price contract with economic price adjustment clauses was awarded without a set-aside designation, reflecting Arthrex's strong competitive position in the federal orthopedic medical device marketplace. The contractor, headquartered in Naples,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order valued at $3,712.50 for a Proximal Tenodesis Implant System from the Defense Logistics Agency's Medical Supply Chain on June 25, 2025. This fixed-price delivery order with economic price adjustment has a completion date of June 30, 2025, and was awarded without a set-aside designation, reflecting Arthrex's strong competitive position in the federal orthopedic medical...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $33,661.14 to Arthrex Inc. for a Proximal Tenodesis Implant System, with an ultimate completion date of June 4, 2025. This fixed-price delivery order with economic price adjustment represents part of Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense Logistics Agency, which is valued at approximately $471 million and runs through September 1, 2029. The contract carries no...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $2,970 to Arthrex Inc., a leading minimally invasive orthopedic medical device manufacturer headquartered in Naples, Florida. The delivery order, issued on October 14, 2025, with an ultimate completion date of October 17, 2025, calls for the supply of a Proximal Tenodesis Implant System. This fixed-price contract with economic price adjustment represents a non-set-aside competitive award to the established...
- Arthrex Inc., a leading minimally invasive orthopedic medical technology company headquartered in Naples, Florida, was awarded a delivery order valued at $6,329.07 for a Proximal Tenodesis Implant System on September 17, 2025. This fixed-price contract with economic price adjustment is issued under the Defense Logistics Agency's Medical Supply Chain and carries an ultimate completion date of September 22, 2025. The award represents a task order under Arthrex's existing Indefinite Delivery...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $28,054.88 on September 4, 2025, for a Proximal Tenodesis Implant System. The contract is a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of September 9, 2025. This award was issued under the Defense Logistics Agency's Medical Supply Chain, a defense-affiliated federal agency responsible for...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $2,970 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain for a Proximal Tenodesis Implant System. Awarded on September 26, 2025, with an ultimate completion date of October 1, 2025, this delivery order was not set aside for any specific business classification. The contract represents a continuation of Arthrex's substantial federal business...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, has been awarded a delivery order valued at $3,712.50 for a Proximal Tenodesis Implant System under the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment was issued on May 29, 2025, with an ultimate completion date of June 3, 2025. The award represents work to be performed in Naples, Florida, and was issued without a set-aside...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, was awarded a $3,889.05 fixed-price delivery order for a Proximal Tenodesis Implant System on September 8, 2025, with completion scheduled for September 11, 2025. The contract was issued by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation, reflecting Arthrex's competitive standing in the federal marketplace. This delivery order represents a task order issued under Arthrex's...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $1,485.00 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain for a Proximal Tenodesis Implant System. Awarded on August 1, 2025, with an ultimate completion date of August 6, 2025, this delivery order was issued without a set-aside designation, reflecting Arthrex's strong competitive position in the federal orthopedic medical device marketplace. The contract utilizes...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D626F271LDelivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a $35,314.35 delivery order to Arthrex Inc. on November 18, 2025, for a Proximal Tenodesis Implant System. This fixed-price contract with economic price adjustment features an ultimate completion date of November 21, 2025, and will be performed at Arthrex's headquarters in Naples, Florida. The award carries no set-aside designation, reflecting Arthrex's strong competitive position in federal orthopedic procurement. Arthrex Inc., a leading global manufacturer of minimally invasive orthopedic medical technologies and surgical implants, has established itself as a primary supplier to Department of Defense and Department of Veterans Affairs healthcare systems. This delivery order is issued under Arthrex's existing single-award Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency's Medical Supply Chain, valued at $471 billion and effective through September 1, 2029. The master contract authorizes procurement of comprehensive orthopedic products and surgical technologies supporting VA medical centers and Department of Defense healthcare facilities nationwide. As a prime contractor with demonstrated substantial federal contracting capability, Arthrex supplies surgical implants, arthroscopic instruments, joint replacement technologies, and biologics tailored to meet the orthopedic healthcare requirements of military personnel and veterans across multiple surgical specialties.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.3k | 11/18/25 |